Semiconductor giant AMD (NASDAQ: AMD) is taking an equity stake in quantum computing developer PsiQuantum as part of an expanded partnership to co-design next-generation infrastructure integrating quantum processors with high-performance computing (HPC) and AI.
📌 Partnership Scope & Technical Architecture:
• Undisclosed Equity Stake: AMD plans to invest equity into Palo Alto-based PsiQuantum (financial terms undisclosed) while broadening collaboration beyond Versal FPGAs to include Instinct GPUs, EPYC CPUs, and the ROCm software stack.
• Photonic Quantum Integration: PsiQuantum brings its silicon photonics platform—which uses optical pulses of light to transmit and process data—to build fault-tolerant, utility-scale quantum architectures.
• Breakthrough Oncology Simulations: PsiQuantum’s pharmaceutical research workflows are already running on AMD GPUs, delivering breakthrough accuracy in simulating covalent inhibitors used in oncology drug discovery.
📌 Federal & Institutional Momentum:
• $2B CHIPS Act Backing: The deal follows the US Commerce Department’s May initiative to acquire minority stakes across nine quantum firms under a $2 billion CHIPS Act program, including a $100 million commitment to PsiQuantum.
💡 Market Takeaway: Utility-scale quantum computers cannot operate in isolation—they rely heavily on classical supercomputing for real-time error correction, calibration, and hybrid simulation. By pairing Instinct GPUs and EPYC processors with photonic quantum systems, AMD positions itself as the foundational classical compute layer for the emerging quantum economy.